The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.

This study suggests that SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 may be potential targets for the clinical diagnosis, prognosis, and treatment of ccRCC patients.
PMID: 32461965 [PubMed - in process]

Source: Biomed Res - May 30, 2020 Category: Research Authors: Kang W, Zhang M, Wang Q, Gu D, Huang Z, Wang H, Xiang Y, Xia Q, Cui Z, Jin X Tags: Biomed Res Int Source Type: research